Trials / Recruiting
RecruitingNCT06134544
Effect of IMO on Intestinal Microbiota Translocation in Cirrhosis
Effect of Isomaltooligosaccharides on Intestinal Bacterial Translocation in Patients With Liver Cirrhosis: a Single-center, Single-arm Study
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 18 (estimated)
- Sponsor
- Nanfang Hospital, Southern Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this intervention clinical trial is to learn about the protection of isomaltooligosaccharides (IMO) on intestinal bacterial translocation in patients with liver cirrhosis. The main question is to answer the changes of LPS after adminstration of IMO.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Isomaltooligosaccharides (IMO) | Patients will still receive standard treatment, including medicine and other invasive treatment. |
Timeline
- Start date
- 2023-11-25
- Primary completion
- 2024-06-01
- Completion
- 2024-07-01
- First posted
- 2023-11-18
- Last updated
- 2024-04-12
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06134544. Inclusion in this directory is not an endorsement.